|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003440,
umls-concept:C0017262,
umls-concept:C0019552,
umls-concept:C0086511,
umls-concept:C0206460,
umls-concept:C0332283,
umls-concept:C0439810,
umls-concept:C0442027,
umls-concept:C0668961,
umls-concept:C0966370,
umls-concept:C1171362,
umls-concept:C1515670,
umls-concept:C1707455,
umls-concept:C1708528,
umls-concept:C1861172,
umls-concept:C2603343
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2003-12-16
|
|
pubmed:abstractText |
Ximelagatran and its subcutaneous (s.c.) form melagatran are novel direct thrombin inhibitors for the prevention and treatment of thromboembolic disease.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1538-7933
|
|
pubmed:author |
pubmed-author:AgnelliGG,
pubmed-author:AnderssonMM,
pubmed-author:CohenA TAT,
pubmed-author:DahlO EOE,
pubmed-author:EXPRESS Study Group,
pubmed-author:ErikssonB IBI,
pubmed-author:EskilsonCC,
pubmed-author:FreijAA,
pubmed-author:KäleboPP,
pubmed-author:LassenM RMR,
pubmed-author:MouretPP,
pubmed-author:PanfilovSS,
pubmed-author:RosencherNN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2490-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14675083-Adult,
pubmed-meshheading:14675083-Aged,
pubmed-meshheading:14675083-Aged, 80 and over,
pubmed-meshheading:14675083-Anticoagulants,
pubmed-meshheading:14675083-Arthroplasty, Replacement, Hip,
pubmed-meshheading:14675083-Arthroplasty, Replacement, Knee,
pubmed-meshheading:14675083-Azetidines,
pubmed-meshheading:14675083-Benzylamines,
pubmed-meshheading:14675083-Double-Blind Method,
pubmed-meshheading:14675083-Enoxaparin,
pubmed-meshheading:14675083-Female,
pubmed-meshheading:14675083-Glycine,
pubmed-meshheading:14675083-Hemorrhage,
pubmed-meshheading:14675083-Humans,
pubmed-meshheading:14675083-Male,
pubmed-meshheading:14675083-Middle Aged,
pubmed-meshheading:14675083-Preoperative Care,
pubmed-meshheading:14675083-Therapeutic Equivalency,
pubmed-meshheading:14675083-Thrombin,
pubmed-meshheading:14675083-Thromboembolism,
pubmed-meshheading:14675083-Venous Thrombosis
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study.
|
|
pubmed:affiliation |
Department of Orthopedics, Sahlgrenska University Hospital/Ostra, Göteborg, Sweden. b.eriksson@orthop.gu.se
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
